The method of therapeutic effects on the human body

 

(57) Abstract:

The invention relates to medicine. Provide an introduction to the human body corresponding pathology aqueous liquid pharmaceutical preparation, pre-treated by physical factors. Treatment is carried out in three stages. In the first stage for at least 3 minutes on the aqueous liquid pharmaceutical preparation is affected by low-frequency oscillations with power, ensuring the emergence of the phenomenon of acoustic cavitation. In the second stage, carried out simultaneously exposed to the drug constant electric field with a strength of not less than 15 kV/cm and low-frequency ultrasonic vibrations with the ever-decreasing power to the disappearance of the phenomenon of cavitation. At the third stage for at least 15 minutes to effect a constant electric field with a magnitude of tension is equal to the magnitude of the electric field intensity at the second stage of processing. The drug can be treated as homogeneous and inhomogeneous constant electric field. The invention improves the efficiency of therapeutic effects. 2 C.p. f-crystals.

The invention relates to biologicheskii activity and can be used for treatment of various diseases.

The closest analogue is the treatment, which consists in the introduction into the body of the corresponding pathology aqueous liquid pharmaceutical preparation, pre-processed physical factor to increase its biological activity (see EN 2020961 C1, description). As a physical factor in the known method uses low frequency ultrasound waves near the threshold of cavitation.

However, the known method of therapeutic effects has the following disadvantages. When treatment effects are only unstable medication that reduces the scope of application of the method. Used modal parameters pre-treatment drug low frequency ultrasonic vibrations do not allow to achieve a high level of ordering of liquid crystalline lattice of a drug that reduces its biological activity compared to the maximum possible and, therefore, reduces the efficiency of the method.

The invention is directed to improving the efficiency of therapeutic effects due to the use of aqueous liquid pharmaceutical preposterous fact, a method of therapeutic effects by introducing into the human body corresponding pathology aqueous liquid pharmaceutical preparation, pre-treated by physical factors to improve its biological activity, the processing of aqueous liquid pharmaceutical preparation is carried out in three stages, the first stage for at least 3 minutes on the aqueous liquid pharmaceutical preparation is affected by low-frequency oscillations with power, ensuring the emergence of the phenomenon of acoustic cavitation in the second stage, carried out simultaneously exposed to the drug constant electric field with a strength of not less than 15 kV/cm and low-frequency ultrasonic vibrations with a gradually decreasing the power to the disappearance of the phenomenon of cavitation, and at the third stage for at least 15 minutes to effect a constant electric field with a magnitude of tension is equal to, the magnitude of the electric field intensity at the second stage of processing.

In the method of processing at the second and third stages can be carried out using both uniform and non-uniform DC electric field.

It is known that the atrasheniya relationships between associates (see I. E. Alpiner. The ultrasound. Physico-chemical and biological action. - M.: State. ed. physical-Mat. literature, 1963, S. 23).

In the proposed method when processing the aqueous liquid pharmaceutical preparation in the first phase for at least 3 minutes effect of low-frequency ultrasonic vibrations with power, ensuring the phenomenon of acoustic cavitation, resulting in the fibrous structure of the drug.

During the second stage under the simultaneous effect of a constant electric field with a strength of not less than 15 kV/cm and low-frequency ultrasonic vibrations with a gradually decreasing the power to the disappearance of cavitation are intramolecular rearrangement, and a new more streamlined compared to the original liquid-crystal lattice of the drug. Due to the formation of more ordered structure of the drug increases its biological activity.

In addition, when processing the aqueous liquid pharmaceutical drug a constant electric field changes its electro-physico-chemical parameters, in particular e changes the pH), that significantly enhances the activity of the drug.

Simultaneous exposure to the drug of ultrasound and electric field can increase the intensity of the proceeding in the treated preparation processes.

During the third stage is achieved stabilization characteristics of the drug, which is then stored for a long time.

As shown by experimental studies with the drug, processed in accordance with the proposed methodology in the human body improves the rheological properties of the blood, improves circulation, normalization of vascular tone, which allows you several times to increase the absorption of the drug, and consequently, to increase the efficiency of therapeutic effects. Furthermore, since the proposed method can be processed any aqueous liquid pharmaceutical preparations, it can significantly extend the scope of use of the method.

The method is as follows.

Depending on the pathology, the patient is prescribed for treatment procedures aqueous liquid pharmaceutical preparation which is prior the I electrodes, connected to a source of high voltage, in the range of low-frequency ultrasonic vibrations generated by the low frequency generator of ultrasonic vibrations is arranged to control the power output fluctuations.

At the first stage set the capacity of low-frequency ultrasonic vibrations, which in this preparation occurs the phenomenon of acoustic cavitation and impact vibrations for at least 3 minutes.

In the second stage, gradually reduce the power fluctuations to the disappearance of cavitation and simultaneously to the electrodes serves voltage from a high voltage source providing an electric field with a strength of not less than 15 kV/see

In the third stage act only constant electric field for at least 15 minutes in the mode corresponding to the second stage of processing.

During the formation of homogeneous DC electric field using electrodes with identical shapes and dimensions, and for the formation of inhomogeneous DC electric field with different shapes and sizes.

Thus treated medicinal liquid slurry of priest processed drug, and from the processed volume and is determined experimentally for each drug.

The effectiveness of the treatment is confirmed by numerous studies.

Example 1.

Patient K., 62 years. Diagnosis: Chronic spastic colitis.

Complaint: on a periodic pain in the paraumbilical area, pull, paroxysmal character, without clear localization, without irradiation. Sick for the last 5-6 years, took antispasmodics, with varying effect.

Patient S., 64 years. Diagnosis and similar history.

For monotherapy patient K. was used a solution of sodium chloride 0.9 per cent, pre-treated in this way, intravenous drip 1 time per day, for 10 days.

As a result, the patient K., 62 years, for treatment of which was applied a solution of sodium chloride at 0.9%, after the second injection of the drug showed significant improvement: pain became less intense, the interval between attacks increased significantly; 7-th day of treatment the pain is completely gone and was not renewed within one month of the dynamic observation.

At the same time, the patient C. on the background of the introduction of the solution of sodium x is then forced to use to treat this patient drugs of different pharmgroup.

Example 2

Patient N., 71. The diagnosis of encephalopathy on the background of atherosclerosis of cerebral vessels.

Complaint: on a periodic headaches, episodes of dizziness, nausea. Suffering from this disease over the last 8-10 years, was treated as an outpatient and inpatient with varying degrees of success.

Patient C., 72 years. Diagnosis and complaints are the same.

On the background of intravenous patient N. R-RA / kg, 100 ml of 0.9% solution of sodium chloride, specially processed in this procedure, daily for 7 days starting with the first admission, the patient's condition improved significantly. Dizziness decreased in time and intensity, disappeared nausea, vomiting was not repeated on the 7th day after the start of treatment - dizzy spells and headaches almost didn't bother, marks a significant improvement of health.

At the same time in a patient Century, 72 years, in the treatment of which used the same drug in 100 ml of 0.9% solution of sodium chloride, not processed, a moderate improvement in the condition and the severity of symptoms was less of a permanent nature; dizzy spells become less intense only to the 7-th duechebag impact by introducing into the human body corresponding pathology aqueous liquid pharmaceutical preparation, pre-processed physical factor to increase its biological activity, wherein the processing of the aqueous liquid pharmaceutical preparation is carried out in three stages, the first stage for at least 3 min in aqueous liquid pharmaceutical preparation is affected by low-frequency oscillations with power, ensuring the emergence of the phenomenon of acoustic cavitation in the second stage, carried out simultaneously exposed to the drug constant electric field with a strength of not less than 15 kV/cm and low-frequency ultrasonic vibrations with the ever-decreasing power to the disappearance of the phenomenon of cavitation, and the third stage for at least 15 min influenced by direct electric field with a magnitude of tension, equal to the magnitude of the electric field intensity at the second stage of processing.

2. The method according to p. 1, wherein the treatment is carried out uniform constant electric field.

3. The method according to p. 1, wherein the treatment is carried out inhomogeneous constant electric field.

 

Same patents:

The invention relates to the field of pharmaceutical industry and relates to a medicinal product of Vinpocetine
The invention relates to medicine, namely to emergency cardiology, and can be used in the prehospital and hospital patients for the prevention and treatment of coronary heart disease (CHD)

The invention relates to a new group of pyrrole, in particular 1-(2,4,6-trimetilfenil)-2-[(2-hydroxy-3-phenyloxy)-N-substituted-aminomethyl]pyrrole General formula

where VI, R=-H, VIa R=-C(O)H, VIIŠ± R=-C(O)CH3, VIIIa R=-CH3, VIIIŠ± R=-C2H5and their pharmaceutically acceptable salts of dicarboxylic acids, which have anti-arrhythmic and anti-ischemic activity and intensity of effect exceeds applicable in the clinic verapamil, amiodarone and lidocaine
The invention relates to medicine, specifically to cardiology, and relates to methods of treatment of acute coronary syndrome without ST segment elevation
The invention relates to medicine and can be used in cardiology and gastroenterology
The invention relates to the field of medicine and is suitable for treating disorders of the peripheral and cerebral circulation, including obliterating endarteritis, Raynaud's disease, atherosclerotic cerebrovascular disease, ischemic heart disease, ischemic conditions after myocardial infarction, vascular pathology of the organs of sight and hearing, diabetic angiopathy

The invention relates to the field of pharmaceutical industry and relates to anti-money

The invention relates to benzoylpyridine formula I

where R(1) denotes CF3; one of the substituents R(2) and R(3) represents hydrogen; and the other of the substituents R(2) or R(3) represents-CH(CH3)-CH2OH; R(4) denotes methyl, and their pharmaceutically acceptable salts

The invention relates to medicine, in particular to a gastroenterologist

The invention relates to medicine

The invention relates to medicine and concerns NTSH-WALL solution for injection 2% spasmolytic action

The invention relates to the field of Biophysics

The invention relates to medicine, in particular to the dentist, and can be used for the treatment of a fracture of the lower jaw, complicated by suppuration bone wounds

The invention relates to the field of dentistry and refers to funds that have a stimulating effect on the processes of cell renewal

The invention relates to the field of dentistry
The invention relates to dentistry and concerns of the medicinal product for the treatment of inflammatory diseases of the oral cavity

The invention relates to the field of dentistry and relates to adhesives for dentures

The invention relates to the field of dentistry and concerns the means of delivering drugs to care for the oral cavity
The invention relates to medicine
Up!